|
Video: What is a Stock Split?
|
|
T2 Biosystems is an in vitro diagnostics company and engaged in the detection of sepsis-causing pathogens and antibiotic resistance genes. Co.'s products include: T2Dx® Instrument, which runs diagnostic tests from patient samples; T2Candida® Panel, which is a direct-from-blood test that identifies the lethal form of blood stream infections that cause sepsis candidemia; T2Bacteria® Panel, which is a direct-from-blood test that detects bacterial pathogens associated with sepsis; T2Resistance® Panel, which is a direct-from-blood test that detects resistance genes from both gram-positive and gram-negative pathogens; and T2SARS-CoV-2 Panel, which detect SARS-CoV-2, the coronavirus in patients. According to our TTOO split history records, T2 Biosystems has had 2 splits. | |
|
T2 Biosystems (TTOO) has 2 splits in our TTOO split history database. The first split for TTOO took place on October 13, 2022. This was a 1 for 50 reverse split, meaning for each 50 shares of TTOO owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 20 share position following the split. TTOO's second split took place on October 13, 2023. This was a 1 for 100 reverse split, meaning for each 100 shares of TTOO owned pre-split, the shareholder now owned 1 share. For example, a 20 share position pre-split, became a 0.2 share position following the split.
When a company such as T2 Biosystems conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the TTOO split history from start to finish, an original position size of 1000 shares would have turned into 0.2 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into T2 Biosystems shares, starting with a $10,000 purchase of TTOO, presented on a split-history-adjusted basis factoring in the complete TTOO split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
08/08/2014 |
|
End date: |
03/28/2024 |
|
Start price/share: |
$67,000.00 |
|
End price/share: |
$3.00 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-100.00% |
|
Average Annual Total Return: |
-64.60% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$0.45 |
|
Years: |
9.64 |
|
|
|
Date |
Ratio |
10/13/2022 | 1 for 50 | 10/13/2023 | 1 for 100 |
|
|